SouthState Corp’s Merck MRK Stock Holding History

SouthState Corp’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.64M	Sell	30,236 -113	-0.4%	-$13K	0.17%	111
2025 Q4	$3.19M	Sell	30,349 -1,692	-5%	-$159K	0.14%	119
2025 Q3	$2.69M	Sell	32,041 -3,641	-10%	-$300K	0.12%	125
2025 Q2	$2.82M	Buy	35,682 +1,436	+4%	+$114K	0.12%	128
2025 Q1	$3.07M	Buy	34,246 +1,696	+5%	+$158K	0.14%	119
2024 Q4	$3.24M	Sell	32,550 -1,494	-4%	-$154K	0.21%	94
2024 Q3	$3.87M	Sell	34,044 -95	-0.3%	-$11.3K	0.27%	87
2024 Q2	$4.23M	Sell	34,139 -467	-1%	-$60.2K	0.31%	79
2024 Q1	$4.57M	Buy	34,606 +124	+0.4%	+$15.3K	0.36%	74
2023 Q4	$3.76M	Sell	34,482 -1,304	-4%	-$135K	0.32%	77
2023 Q3	$3.68M	Sell	35,786 -264	-0.7%	-$28.5K	0.35%	70
2023 Q2	$4.16M	Buy	36,050 +693	+2%	+$78.7K	0.37%	69
2023 Q1	$3.76M	Buy	35,357 +104	+0.3%	+$11.2K	0.35%	75
2022 Q4	$3.91M	Buy	35,253 +619	+2%	+$63.3K	0.36%	72
2022 Q3	$2.98M	Buy	34,634 +436	+1%	+$38.9K	0.3%	82
2022 Q2	$3.12M	Buy	34,198 +5,217	+18%	+$462K	0.29%	82
2022 Q1	$2.38M	Buy	28,981 +1,689	+6%	+$133K	0.19%	106
2021 Q4	$2.09M	Buy	27,292 +24	+0.1%	+$1.91K	0.16%	114
2021 Q3	$2.05M	Sell	27,268 -1,619	-6%	-$123K	0.17%	112
2021 Q2	$2.25M	Sell	28,887 -3,249	-10%	-$242K	0.19%	105
2021 Q1	$2.36M	Sell	32,136 -3,214	-9%	-$237K	0.22%	95
2020 Q4	$2.76M	Sell	35,350 -507	-1%	-$38.8K	0.27%	85
2020 Q3	$2.84M	Buy	35,857 +1,640	+5%	+$128K	0.3%	83
2020 Q2	$2.52M	Buy	34,217 +348	+1%	+$26.2K	0.31%	76
2020 Q1	$2.49M	Sell	33,869 -2,927	-8%	-$230K	0.37%	69
2019 Q4	$3.19M	Sell	36,796 -1,339	-4%	-$110K	0.37%	73
2019 Q3	$3.06M	Sell	38,135 -2,793	-7%	-$224K	0.38%	74
2019 Q2	$3.27M	Sell	40,928 -6,924	-14%	-$530K	0.38%	79
2019 Q1	$3.8M	Buy	47,852 +63	+0.1%	+$4.71K	0.39%	77
2018 Q4	$3.48M	Buy	47,789 +1,168	+3%	+$82.5K	0.4%	79
2018 Q3	$3.16M	Sell	46,621 -5,342	-10%	-$340K	0.32%	90
2018 Q2	$3.01M	Sell	51,963 -1,787	-3%	-$101K	0.34%	88
2018 Q1	$2.79M	Sell	53,750 -2,413	-4%	-$130K	0.32%	88
2017 Q4	$3.02M	Buy	56,163 +4,135	+8%	+$229K	0.33%	86
2017 Q3	$3.18K	Sell	52,028 -777	-1%	-$47.1K	0.36%	84
2017 Q2	$3.23M	Sell	52,805 -2,382	-4%	-$145K	0.42%	81
2017 Q1	$3.35M	Sell	55,187 -5,627	-9%	-$341K	0.44%	77
2016 Q4	$3.42M	Sell	60,814 -623	-1%	-$36.5K	0.49%	70
2016 Q3	$3.66M	Sell	61,437 -19,574	-24%	-$1.14M	0.56%	63
2016 Q2	$4.45M	Sell	81,011 -913	-1%	-$48.6K	0.67%	51
2016 Q1	$4.14M	Sell	81,924 -6,714	-8%	-$329K	0.64%	54
2015 Q4	$4.47M	Buy	88,638 +10,501	+13%	+$529K	0.7%	51
2015 Q3	$3.68M	Sell	78,137 -3,319	-4%	-$176K	0.56%	64
2015 Q2	$4.43M	Buy	81,456 +4,391	+6%	+$246K	0.62%	57
2015 Q1	$4.23M	Buy	77,065 +12,991	+20%	+$736K	0.6%	55
2014 Q4	$3.47M	Buy	64,074 +13,447	+27%	+$749K	0.54%	60
2014 Q3	$2.86M	Buy	50,627 +6,572	+15%	+$369K	0.44%	73
2014 Q2	$2.43M	Sell	44,055 -207	-0.5%	-$11.3K	0.4%	84
2014 Q1	$2.4M	Buy	44,262 +395	+0.9%	+$20.5K	0.39%	86
2013 Q4	$2.1M	Buy	43,867 +2,549	+6%	+$117K	0.35%	89
2013 Q3	$1.88M	Buy	41,318 +4,851	+13%	+$221K	0.35%	92
2013 Q2	$1.62M	Buy	+36,467	New	+$1.63M	0.34%	86

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SouthState Corp's MRK Position: Q1 2026 in Review

SouthState Corp reduced its Merck (MRK) stake by 0.37% in Q1 2026, selling an estimated $13K and leaving 30,236 shares worth $3.64M. The position accounts for 0.17% of the portfolio, ranked #111.

SouthState Corp first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.57M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

SouthState Corp held 30,236 shares of Merck worth $3.64M as of Q1 2026.
SouthState Corp sold 113 Merck shares in Q1 2026, an estimated $13K.
Merck made up 0.17% of SouthState Corp's portfolio in Q1 2026, its #111 holding.
SouthState Corp first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
SouthState Corp's Merck position peaked at $4.57M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.